US FDA Principal Deputy Commissioner Bumpus Leaving At Year’s End, Creating Leadership Void

Namandje Bumpus' departure means there is no obvious, internal candidate to serve as acting commissioner when President-elect Donald Trump takes office in January and the Senate works to confirm a new leader.